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Abstract
We have previously described enrichment of antigen-presenting
HLA-DR+ nuclear RelB+ dendritic cells (DCs) in rheumatoid
arthritis (RA) synovium. CD123+HLA-DR+ plasmacytoid DCs
(pDCs) and their precursors have been identified in human
peripheral blood (PB), lymphoid tissue, and some inflamed
tissues. We hypothesized recruitment of pDCs into the inflamed
RA synovial environment and their contribution as antigen-
presenting cells (APCs) and inflammatory cells in RA. CD11c+
myeloid DCs and CD123+ pDCs were compared in normal and
RA PB, synovial fluid (SF), and synovial tissue by flow cytometry,
immunohistochemistry, and electron microscopy and were
sorted for functional studies. Nuclear RelB-CD123+ DCs were
located in perivascular regions of RA, in a similar frequency to
nuclear RelB+CD123-  DCs, but not normal synovial tissue
sublining. Apart from higher expression of HLA-DR, the numbers
and phenotypes of SF pDCs were similar to those of normal PB
pDCs. While the APC function of PB pDCs was less efficient
than that of PB myeloid DCs, RA SF pDCs efficiently activated
resting allogeneic PB T cells, and high levels of IFN-γ, IL-10, and
tumor necrosis factor α were produced in response to
incubation of allogeneic T cells with either type of SF DCs. Thus,
pDCs are recruited to RA synovial tissue and comprise an APC
population distinct from the previously described nuclear RelB+
synovial DCs. pDCs may contribute significantly to the local
inflammatory environment.
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Introduction
Plasmacytoid dendritic cells (pDCs) are a distinct popula-
tion of antigen-presenting cells (APCs) with the capacity
for potent antigen-presenting function and production of
large amounts of cytokines, including tumor necrosis factor
(TNF)-α and IFN-α. Human pDCs can be identified by cell-
surface expression of MHC molecules, the α-chain of the
IL-3 receptor (CD123), and the presence of blood den-
dritic-cell (DC) antigens known as BDCA2 and BDCA4 in
a proportion of cells [1]. In comparison with CD11c+ mye-
loid DCs, pDCs display a distinct set of chemokine and
Toll-like receptors [2-4]. In response to viruses and CpG
DNA, pDCs become activated to produce IFN-α and their
APC function is enhanced [5-8]. While pDCs were first
demonstrated in the T-cell areas of lymph nodes [5,9], pre-
cursors of this DC population have been isolated from sev-
eral sources, including normal peripheral blood (PB),
thymus, fetal liver, and bone marrow [10]. Although they do
not reside in normal peripheral tissues, pDCs have been
shown to infiltrate certain inflamed tissues and tumor sites,
including the skin in psoriasis and lupus, the cerebrospinal
fluid in multiple sclerosis, and melanoma and ovarian carci-
noma [11-15]. While pDCs play an important effector role
in viral disease, being the major producers of IFN-α and
having a primary role in innate immunity, there is also evi-
dence that they may play an immunoregulatory role,
through the induction of Th2 (T helper 2)-type cytokines
[9,16-18].
APC = antigen-presenting cell; DC = dendritic cell; ELISA = enzyme-linked immunosorbent assay; FCS = fetal calf serum; FITC = fluorescein isothi-
ocyanate; IFN = interferon; IL = interleukin; NK = natural killer; PB = peripheral blood; pDC = plasmacytoid DC; PE = phycoerythrin; RA = rheumatoid 
arthritis; SF = synovial fluid; TNF = tumor necrosis factor.Arthritis Research & Therapy    Vol 7 No 2    Cavanagh et al.
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The synovial autoimmune reaction of rheumatoid arthritis
(RA) is characterized by lymphocyte, macrophage, and DC
infiltration that can progress to the development of lym-
phoid tissue in established disease [19-21]. DCs are likely
to contribute to the formation and maintenance of such
organized lymphoid tissue and antigen presentation in RA
and other autoimmune lesions [22-24]. We have previously
shown that the effector site in RA synovial tissue is
enriched in differentiated myeloid DCs, which express
CD33, CD11c, MHC and costimulatory molecules, and
nuclear RelB [21,25]. Translocation of RelB to the nucleus
of myeloid DCs is associated with APC function, particu-
larly through increased expression of MHC molecules
CD86 and CD40 [26].
The proinflammatory cytokines TNF-α and IL-1β are key
contributors to the inflammatory cytokine cascade in RA
[27,28]. This relates to a number of actions, but activation
of the endothelium by TNF-α is particularly important in cel-
lular recruitment to the synovium [29-31]. Since RA is char-
acterized by endothelial activation, leukocyte recruitment,
and the development of high endothelial venules, we
hypothesized that pDCs would be enriched in inflamed but
not normal synovium. Since the functional role of pDCs in
disease pathogenesis is only partly understood, we also
wished to address whether these cells represent a popula-
tion distinct from the described nuclear RelB+ synovial
DCs, and whether they may contribute as APCs or inflam-
matory cells in RA [21].
Materials and methods
Patients and controls
Thirty patients who fulfilled the American College of Rheu-
matology criteria for RA were included [32]. Of these, 10
provided synovial fluid (SF) samples and 27 provided PB
samples. Of the 30 patients, 80% were seropositive, 62%
were female, and 73% were taking at least one disease-
modifying antirheumatic drug or low-dose prednisone or
both. Synovial tissue was obtained at arthroscopy from
seven patients with RA, of whom three were untreated and
four were taking at least one disease-modifying antirheu-
matic drug and low-dose prednisone. The duration of dis-
ease ranged from 0.5 to 18 years. In addition, we studied
synovial tissue from four healthy individuals with nonspe-
cific knee pain undergoing arthroscopy, one patient who
had had psoriatic arthritis for 8 years, and one patient who
had had ankylosing spondylitis for 30 years. Each patient
with spondyloarthropathy was taking sulfasalazine. No
patient in the study was taking biologics. Synovial tissue
was provided by Dr Malcolm Smith (Repatriation Hospital,
Adelaide, Australia). PB buffy coats prepared from 30
healthy donors were obtained from the Red Cross Blood
Transfusion Service (Brisbane, QLD, Australia). The study
was approved by the Research Ethics Committee of the
Princess Alexandra Hospital.
Culture medium and cell isolation
All cells were cultured in RPMI 1640 (Gibco, Life Technol-
ogies, Mulgrave, VIC, Australia) supplemented with 10%
FCS (CSL Ltd, Parkville, VIC, Australia), 0.3 mg/ml L-
glutamine (Trace Biosciences, Castle Hill, NSW, Australia),
0.12 mg/ml benzylpenicillin (CSL), and 10 µg/ml gen-
tamicin (Delta West, Pharmacia and Upjohn, Spring Hill,
QLD, Australia). The monoclonal antibodies used in this
study include FITC, phycoerythrin (PE), and purified anti-
CD11c, CD14-PerCP, PE, biotinylated and purified anti-
CD123, CD86-FITC (all from BD Pharmingen, San Diego,
CA, USA), BDCA2-FITC (Miltenyi Biotech, San Francisco,
CA, USA), HLA-DR-biotin (Coulter Immunotech, Fullerton,
CA, USA), CD40-FITC (Biolegend, San Diego, CA, USA),
CD80-FITC (Cymbus Biotech, Chandlers Ford, Hants,
UK), CD68 (Kp-1, DAKO, Carpinteria, CA, USA), RelB (C-
19, Santa Cruz Biotech, Santa Cruz, CA, USA), and bioti-
nylated Ulex europaeus agglutinin I (Vector Laboratories,
Burlingame, CA, USA).
Mononuclear cells were prepared from normal or RA PB or
RA SF by density gradient centrifugation over Ficoll-Paque
(Pharmacia Biotech, Uppsala, Sweden) as described else-
where [33]. T cells were purified from PB mononuclear
cells by passing the cells over a nylon wool column, fol-
lowed by immunomagnetic depletion of remaining mono-
cytes, DCs, B cells, and NK (natural killer) cells using
monoclonal antibodies against CD14, CD16, CD19,
CD56, and HLA-DR (all from BD Pharmingen), followed by
goat antimouse immunoglobulin magnetic beads, then pas-
sage through a strong magnetic field (MACS, Miltenyi Bio-
tech), and collection of the unbound fraction. On analysis
by flow cytometry, the unbound fraction routinely contained
95–98% CD3+ T cells. DC-enriched non-T cells were pro-
duced by immunomagnetic depletion of T, B, and NK cells
from non-T cells, by incubation with monoclonal antibodies
against CD19, CD16, CD56, and CD3.
Flow cytometric analysis and selection of cells by cell 
sorting
To enumerate CD123+  and CD11c+  subsets of DCs,
mononuclear cells from normal PB or RA SF were stained
for four-colour flow cytometry as described elsewhere [33],
using monoclonal antibodies against CD14-PECy5,
CD11c-FITC, CD123-PE, and HLA-DR-APC. Live CD14-
HLA-DR+ mononuclear cells were gated for analysis. Sub-
set percentages are expressed as percentage of total
mononuclear cells. Listmode data were analyzed using
Winlist 2.0 software (Verity Software House, Topsham,
ME, USA). For sorting, PB or SF DC-enriched non-T cells
stained with the same four markers were sorted using the
Moflo flow cytometer (DAKO), gating on CD14-HLA-DR+
and either CD123+CD11c-  or CD11c+CD123-  cells,
respectively. For phenotypic analysis, mononuclear cells
from PB or SF were stained with CD14-PECy5, CD123-PEAvailable online http://arthritis-research.com/content/7/2/R230
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or CD11c-PE, HLA-DR-APC, and either a fourth mono-
clonal antibody or isotype control monoclonal antibody
conjugated with FITC. DCs were gated as described
above.
Electron microscopy
Electron microscopy of freshly sorted cells was carried out
as described elsewhere [5]. After fixation in 2.5% glutaral-
dehyde in phosphate-buffered saline, the cells were post-
fixed with an aqueous solution of 1% OsO4 containing
1.5% K4Fe(CN)6. Subsequently, the specimens were
dehydrated in an alcohol series and embedded into epon.
Ultrathin sections (50 nm) were contrasted with lead citrate
and uranyl acetate and studied with a CM100 electron
microscope (Philips, Eindhoven, The Netherlands).
Mixed lymphocyte reactions and cytokine analysis
Various numbers of sorted PB or RA SF DCs were incu-
bated with 105 allogeneic PB T cells in triplicate wells for 5
days, as described elsewhere [33]. Supernatants were
removed from some cultures and [3H]thymidine (1 µCi/
well, ICN Biochemicals) was added to the remainder for the
final 18 h. Cells were harvested onto glass-fiber filter mats
and the incorporation of [3H]thymidine was determined by
liquid scintillation spectroscopy (Packard Topcount, Pack-
ard Instrument Co, Meriden, CT, USA). IFN-γ, IL-10, and
TNF-α w e r e  m e a s u r e d  i n  s u p e r n a t a n t s  b y  E L I S A  u s i n g
OptEIA ELISA kits (BD Pharmingen).
Immunohistochemistry
Frozen or paraffin-embedded sections of synovial tissue
from patients with untreated active RA were obtained by
arthroscopic biopsy and supplied by Malcolm Smith (Repa-
triation Hospital, Adelaide, Australia). Normal synovial tis-
sue was obtained at arthroscopy from patients undergoing
arthroscopy for nonspecific knee pain and in whom no
abnormality was found. After fixation with acetone, sections
were stained with anti-CD11c or anti-CD123 using an
immunoperoxidase technique, and revealed with diami-
nobenzidine (brown). Frozen sections were double-stained
with U. europaeus agglutinin I (Ulex), a lectin that specifi-
cally binds endothelial cells (fast red), and anti-CD123
(brown), using a double, immunoperoxidase–immunoalka-
line phosphatase technique as described elsewhere [34].
Formalin-fixed paraffin-embedded sections were antigen-
retrieved in 10 mM citrate buffer at pH6 in an autoclave,
then stained with anti-CD123 (diaminobenzidine, brown)
alone, or in combination with anti-RelB (BCIP, DAKO, pur-
ple). Sections were counterstained with hematoxylin except
when they had been double-stained for CD123 and RelB
and were photographed using a transmitted-light micro-
scope (Leitz Diaplan, Leica, Germany). To quantitate infil-
tration by CD123+ DCs, the number of CD123+Ulex- cells
was counted in sections double-stained with CD123 and
Ulex. Cells were counted in each of the entire sections from
three patients and three normal controls at high power, and
for each biopsy this number was corrected for the area of
the section to obtain the number per mm2. To quantitate
infiltration by CD11c+ cells, the number of these cells was
counted in three high-power fields of the synovial sublining
in sections from three patients and three normal controls.
Statistical analysis
Differences were analyzed using unpaired Student's t-
tests.
Results
CD123+ nuclear RelB- DCs are located in perivascular 
regions of RA synovial tissue
We have previously shown that synovial tissue in RA and
spondyloarthropathy is enriched in differentiated myeloid
DCs that express CD33, CD11c, MHC class II, costimula-
tory molecules, and nuclear RelB [21,25]. Translocation of
RelB to the nucleus is associated with maturation and APC
function of myeloid DCs [26]. These nuclear RelB+ DCs are
absent in normal synovial tissue and are rare in RA SF
[21,23]. To determine whether RA synovial tissue was infil-
trated by CD123+ pDCs in addition to CD11c+ myeloid
cells, frozen synovial tissue sections, either normal or from
patients with RA or spondyloarthropathy, were stained with
CD11c or CD123. CD11c+ cells were found both in the lin-
ing layer and adjacent to vessels in the sublining of normal
synovial tissue. In contrast, CD123 only stained endothelial
cells in the normal tissue (Fig. 1a,1b). In RA synovial tissue,
CD11c again stained cells adjacent to vessels, now within
lymphoid aggregates in the sublining. A population of
CD123+ cells with dendritic appearance was also stained
adjacent to CD123+ blood vessels in RA (Fig. 1c,1d,).
Cells expressing TNF-α in RA synovial tissue were found in
a similar location in serial sections (data not shown), as
demonstrated previously [35]. To confirm the perivascular
CD123+ cells in synovial tissue, normal and RA synovial tis-
sue were double-stained with the endothelial cell marker
Ulex agglutinin (red) and with CD123 (brown). Whereas all
CD123+ structures in normal synovial tissue colocalized
with Ulex agglutinin (orange), single-stained CD123+ cells
(brown) were located in perivascular lymphoid aggregates
and within the lumen of occasional blood vessels in RA syn-
ovial tissue (Fig. 1e,1f). These CD123+ cells are similar in
appearance to those previously demonstrated as CD123+
pDCs in human tonsil, in that they are smaller than CD11c+
myeloid DCs, with shorter dendritic processes, and cell
clusters gave the appearance of locally proliferating cells
(Fig. 1g) [5,36]. While some macrophages can express
CD123, there was no colocalization in synovial tissue of
CD123 and CD68 (data not shown). However, aside from
the dendritic morphology, we cannot exclude that some of
the CD123+ cells stained are mast cells [37]. To determine
whether CD123+ cells in synovial tissue were also nuclear
RelB+, formalin-fixed tissue was double-stained for RelBArthritis Research & Therapy    Vol 7 No 2    Cavanagh et al.
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and CD123 without hematoxylin counterstaining. No
CD123+  cells had translocated RelB to the nucleus,
although some expressed cytoplasmic RelB (Fig. 1h,1i). In
contrast, nuclear staining of RelB was evident in adjacent
CD123- cells (Fig. 1h, arrows). All patients with RA showed
similar infiltration by pDCs and no differences in the cell
numbers or location were noted between patients with RA
or spondyloarthropathy (data not shown).
We quantitated pDCs in normal or RA synovial tissue by
counting CD123+Ulex-  cells in synovial tissue sections
from patients with RA or normal controls stained with
CD123 and Ulex as shown in Fig. 1. Whereas no pDCs
infiltrated the normal tissue, approximately 22 pDCs per
mm2 were identified within the RA tissue (Fig. 2). This
number is similar to the number of nuclear RelB+ differenti-
ated DCs identified previously in RA synovial tissue [38]. In
contrast, CD11c+ cells infiltrated both normal and RA syn-
ovial tissue, with significantly larger numbers in RA (P <
0.05) (Fig. 2). We conclude that the CD123+ cell popula-
tion is most likely a pDC population that infiltrates RA and
spondyloarthropathy but not normal synovial tissue and that
it is distinct from the described nuclear RelB+  DCs
[21,36,39]. CD11c+ cells comprise immature and differen-
tiated myeloid DCs as well as monocytes [1,34]. Differenti-
ated nuclear RelB+ DCs are found within the CD11c+ DC
population in RA and other inflammatory arthritides but not
in normal synovial tissue [21].
CD11c+ and CD123+ DCs in RA SF
Workers in our laboratory have previously shown that RA
SF is enriched in CD11c+CD33brightCD14- myeloid DCs
with efficient APC function [25,40]. However, when freshly
isolated, only a small proportion of SF CD33brightCD14-
DCs have translocated RelB to the nucleus. RA and normal
PB mononuclear cells contain similar proportions of
CD33brightCD14- DCs [25]. To examine plasmacytoid and
myeloid DCs in parallel, we compared RA SF with RA and
healthy, control PB for the proportion of CD123+  and
CD11c+ HLA-DR+CD14- DCs. After purification of mono-
nuclear cells from either normal or RA PB or RA SF by gra-
dient centrifugation, cells were stained with CD123-PE,
CD11c-FITC, CD14-PECy5, and HLA-DR-APC. Polymor-
phonuclear cells were excluded on the basis of forward and
side light-scatter. Since basophils and monocytes can also
express CD123, potential CD123+  non-DCs were
excluded by gating CD14-HLA-DR+ cells [10]. By four-
color analysis, CD14-HLA-DR+CD123+ and CD11c+ DC
populations could be distinguished (Fig. 3). The percent-
ages of CD123+CD11c- pDCs in RA PB and normal PB
were low and did not differ from each other. This observa-
tion contrasts with the reduction in pDCs observed in
blood from patients with systemic lupus erythematosus
[41]. CD11c+CD123- myeloid DCs were more common
than CD123+  DCs in patient and control blood (P  <
0.005), in keeping with previous studies of normal PB [1].
RA SF contained a significantly greater percentage of
Figure 1
Nuclear RelB-CD123+ plasmacytoid dendritic cells (pDCs) are located  in close association with cells expressing tumor necrosis factor (TNF)-α  in lymphoid aggregates of rheumatoid arthritis (RA) synovial tissue Nuclear RelB-CD123+ plasmacytoid dendritic cells (pDCs) are located 
in close association with cells expressing tumor necrosis factor (TNF)-α 
in lymphoid aggregates of rheumatoid arthritis (RA) synovial tissue. 
Sections of frozen normal human synovial tissue (a, b, e) or synovial tis-
sue from a patient with untreated active RA (c, f, g) or formalin-fixed 
sections from a patient with active RA (d, h, i) were stained with anti-
CD11c (brown, a, c), anti-CD123 (brown, b, d), or anti-TNF-α (brown, 
g) using an immunoperoxidase technique. For double staining, sections 
were stained with Ulex (red) and anti-CD123 (brown, e, f, g) or with 
RelB (purple) and CD123 (brown, h, i) using a double, immunoperoxi-
dase–immunoalkaline phosphatase technique. All sections were coun-
terstained with hematoxylin (blue) except h and i, in which the nucleus 
of CD123+ cells appears as a hole. The thick arrow in d identifies a 
blood vessel. Thin arrows denote representative CD123+ perivascular 
DCs (d), representative double-stained vessels (e), a CD123+ cell 
within a blood vessel (f), and nuclei stained by RelB (h). Data are repre-
sentative of at least three separate RA donors in individual experiments. 
Scale bars represent 20 µm.Available online http://arthritis-research.com/content/7/2/R230
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CD11c+ D C s  t h a n  n o r m a l  o r  R A  P B  ( P  < 0.005) – in
accord with previous studies using the markers CD33 and
CD14 [40]. The proportion of CD11c+ DCs in RA SF was
higher than that of RA SF CD123+ DCs (P  < 0.05).
Although the difference was small, the percentage of
CD123+ DCs in RA SF was higher than in RA or control PB
(P < 0.05). The data show that CD123+ DCs are present
in RA SF, and that the ratio of CD11c+ to CD123+ DCs is
similar in RA SF to that in normal or RA PB (approximately
10:1). In RA synovial tissue, mature myeloid nuclear RelB+
and CD123+ DCs have infiltrated perivascular lymphoid
aggregates in similar numbers. Previously, similar numbers
of immature and mature myeloid DCs were identified in RA
synovial tissue [42]. Thus pDCs make up about 30% of
DCs within RA synovial tissue. The present and previously
published data, taken together, show that both pDCs and
myeloid DCs are recruited to RA synovium, with an enrich-
ment of pDCs in synovial tissue relative to blood or SF.
CD123+ PB DCs are immature whereas SF pDCs show 
signs of activation
In normal PB, pDCs circulate as precursors with the poten-
tial for recruitment into tissues in response to chemokines
[2,43]. These precursors exhibit a characteristic plasmacy-
toid morphology on electron microscopy, a cell-surface
phenotype characterized by expression of the BDCA2 anti-
gen, by low levels of costimulatory molecule expression,
and by the potential for IFN-α production in response to
viral or immunostimulatory CpG DNA motifs [1]. We there-
fore analyzed the characteristics of sorted RA SF CD123+
DCs and compared them with control PB CD123+ DCs.
On electron microscopic examination, freshly sorted PB
and SF CD123+ DCs appeared similar, with a smooth sur-
face and abundant rough endoplasmic reticulum in the
cytoplasm. The nucleus was nonlobulated and abundant in
euchromatin and contained a distinct nucleolus (Fig. 4).
CD11c+ PB DCs were morphologically distinct from the
CD123+ pDCs, with a lobulated nucleus and some phago-
cytic vesicles. CD11c+ DCs from SF showed more mem-
brane ruffling and phagocytic activity than those from PB
(Fig. 4). Thus SF CD123+ DCs morphologically resemble
CD123+ DCs in PB, whereas CD11c+ SF DCs display a
greater level of ruffling and phagocytic activity, consistent
with their enhanced level of activation, than CD11c+ circu-
lating precursors [21].
On four-color flow cytometric analysis, gated RA SF CD14-
HLA-DR+CD123+ DCs expressed low levels of CD40,
CD80, and CD86. All or the majority of SF CD123+ DCs
expressed the BDCA2 marker of immature pDC precursors
[1]. This cell-surface phenotype closely resembles that of
control PB CD123+ DC precursors, although BDCA2 was
consistently expressed at high levels only by a subset of
CD123+ HLA-DR+ cells in PB (Fig. 4b). No PB or SF cells
expressed the DC differentiation marker CD83 (data not
shown). However, SF CD123+  and CD11c+  DCs
expressed higher levels of cell-surface HLA-DR than the
corresponding cells in PB, suggesting some cellular activa-
tion within the SF environment [5,10,44]. Thus CD123+
pDCs comprise a small proportion of RA SF mononuclear
cells, which are predominantly immature but show some
evidence of activation in situ. These observations regarding
phenotype and PB and SF numbers are consistent with
findings in two recent studies [39,45].
CD123+ and CD11c+ SF DCs are efficient APCs
We have previously shown that freshly isolated
CD33brightCD14-CD11c+ SF DCs efficiently stimulate rest-
ing T cells in allogeneic mixed lymphocyte reactions [21]. In
contrast, whereas freshly isolated CD11c+ PB DCs are effi-
cient APCs in mixed lymphocyte reactions, CD123+ PB
DCs usually require prior activation in the presence of IL-3
Figure 2
CD123+ dendritic cells (DCs) and CD11c+ cells are enriched in rheumatoid arthritis (RA) synovial tissue (ST) CD123+ dendritic cells (DCs) and CD11c+ cells are enriched in rheumatoid arthritis (RA) synovial tissue (ST). CD123+ DCs were quantitated by 
counting the number of CD123+Ulex- cells in sections double-stained with CD123 and Ulex. Cells were counted in each of the entire sections from 
three patients and three normal controls at high power, and for each biopsy this number was corrected for the area of the section to obtain the 
number/mm2. To quantitate CD11c+ cellular infiltration, the number of CD11c+ cells was counted in three high-power fields of the synovial sublining 
in sections from three patients and three normal controls. Data represent means ± standard error of the mean.Arthritis Research & Therapy    Vol 7 No 2    Cavanagh et al.
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and CD154 for acquisition of APC function in this assay. To
analyse the functional capability of RA SF DCs, CD11c+
and CD123+ DCs were sorted from either normal PB or RA
SF and incubated with freshly isolated normal allogeneic
PB T cells. Freshly isolated PB CD11c+ but not CD123+
DCs efficiently stimulated allogeneic T-cell proliferation and
IFN-γ and IL-10 production in mixed lymphocyte reactions.
Addition of IL-3 made no difference to the T-cell prolifera-
tion in response to CD123+ DCs (data not shown), sug-
gesting that death of the APCs was not responsible. In
contrast, both freshly isolated CD11c+ and CD123+ SF
DCs efficiently stimulated proliferation and IFN-γ and IL-10
production by resting normal allogeneic T cells (Fig. 5). A
recent study demonstrated the capacity of RA SF to inhibit
pDC differentiation in vitro [39]. The current studies are
consistent, in that SF pDCs showed only some evidence of
activation in situ, but once incubated in mixed lymphocyte
reactions in the absence of SF they displayed enhanced
APC function relative to that of PB pDCs. Whereas stimu-
lation of mixed lymphocyte reactions either by CD11c+ or
by CD123+ PB DCs resulted in little TNF-α production,
stimulation by either of these DCs from RA SF resulted in
high levels of TNF-α secretion (Fig. 5). The data indicate
that pDCs have the capacity for enhanced APC function
relative to PB pDCs once removed from the RA SF environ-
ment. Furthermore, at the time of antigen presentation by
SF DCs to T cells, production of a number of cytokines by
either T cells or DCs may be stimulated, including TNF-α,
and this appears to be a characteristic of RA synovial DCs
rather than the subtype of stimulating DCs.
Discussion
Ongoing inflammation in RA involves positive feedback
loops between activated T cells, B cells, DCs,
macrophages, and their products, with destructive conse-
quences for parenchymal cells. Clinical and animal data
indicate that effector-site DCs play an important proinflam-
matory role in the perpetuation of autoimmune disease and
contribute to the lymph-node-like organization of that tissue
[22,46]. This role may be effected by local antigen presen-
tation to CD4+ and CD8+ effector cells, but DC cytokine
and chemokine secretion are also important [47,48]. TNF-
α and IL-1β are important downstream proinflammatory
and destructive cytokines in RA for somatic cells, whose
release is promoted by activation of macrophages. IL-10 is
highly expressed in RA, and IFN-γ is an important T-cell
effector cytokine [49,50].
In the current studies, we show that, in addition to the pre-
viously described population of nuclear RelB+ DCs, a fur-
ther population of nuclear RelB-CD123+ pDCs is located in
perivascular regions of RA but not normal synovial tissue
sublining. Moreover, pDCs were located within blood ves-
sels, and both DC populations were observed in perivascu-
lar areas in which cells producing TNF-α were colocated
[35]. Adherence of CD123+ and CD11c+ DCs to TNF-α-
activated endothelium was higher than to resting endothe-
lium in vitro (data not shown). TNF-α plays an important
role in the recruitment of other leukocytes to RA synovial
Figure 3
CD11c+ dendritic cells (DCs) and CD123+ DCs are present in rheuma- toid arthritis (RA) synovial fluid (SF) CD11c+ dendritic cells (DCs) and CD123+ DCs are present in rheuma-
toid arthritis (RA) synovial fluid (SF). After purification of mononuclear 
cells from either normal or RA peripheral blood (PB) or RA SF, cells 
were stained with CD123-PE, CD11c FITC, CD14-PECy5, and HLA-
DR-APC. Live HLA-DR+CD14- mononuclear cells were gated; polymor-
phonuclear cells were excluded on the basis of forward and side light-
scatter. Scatter plots depict percentage of total PB or SF cells express-
ing the indicated markers for all donors. APC, antigen-presenting cell; 
PBMC, peripheral blood mononuclear cells; PE, phycoerythrin; SFMC, 
synovial fluid mononuclear cells.Available online http://arthritis-research.com/content/7/2/R230
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tissue [29], and this most likely pertains to the recruitment
of pDCs to RA but not normal synovial tissue through
expression of adhesion molecules such as intercellular
adhesion molecule (ICAM)-1, CD62-E, and CD62-P and
interaction with their ligands on pDCs [9,11,51-54]. Fur-
thermore, TNF-α up-regulates synthesis of chemokines by
endothelial cells [55]. During experimentally elicited allergic
rhinitis, CD123+HLA-DR+ pDCs have been shown to be
recruited to human nasal mucosa [11].
The gene for MxA is specifically induced by IFN-α and
therefore identifies a population of activated pDCs. In con-
trast, BDCA2 is a marker of immature pDCs. MxA+ pDCs
have previously been demonstrated in involved lupus skin
Figure 4
Morphology and cell-surface phenotype of dendritic cell (DC) subpopulations Morphology and cell-surface phenotype of dendritic cell (DC) subpopulations. (a) Freshly isolated CD11c+CD123- DCs and CD123+CD11c- DCs 
were sorted from either normal peripheral blood (PB) or rheumatoid arthritis (RA) synovial fluid (SF) according to the gating strategy outlined in the 
legend to Fig. 3 and were then prepared for transmission electron microscopy. Micrographs are representative of three separate donors. Scale bars 
represent 20 µm. (b) Normal PB or RA SF mononuclear cells were stained with CD123-PE, CD14-PECy5, HLA-DR-APC, and either isotype control 
or the depicted marker labelled with FITC. Live HLA-DR+CD14-CD123+ cells or HLA-DR+CD14-CD11c+ cells were gated; polymorphonuclear cells 
were excluded on the basis of forward and side light-scatter. The expression of isotype control (dotted lines) and indicated markers (continuous 
lines) by the gated cells are depicted. Data are from three donors of normal PB or RA SF. APC, antigen-presenting cell; PE, phycoerythrin.Arthritis Research & Therapy    Vol 7 No 2    Cavanagh et al.
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and inflamed tonsil [13]. In RA synovial tissue, BDCA2 was
shown to stain fewer cells than CD123 or MxA, suggesting
differentiation in situ of a large proportion of pDCs into
cells with a capacity for production of IFN-α and other
cytokines. Together, the current and previous studies
demonstrate recruitment of pDCs to normal lymphoid
organs as well as inflammatory sites, with local differentia-
tion, but no recruitment to normal peripheral tissues. In con-
trast, CD11c+ myeloid precursors populate normal resting
tissues, as shown here, but additional CD11c+ myeloid cel-
lular recruitment takes place at inflammatory sites, where
RelB nuclear translocation takes place [21,56]. We have
previously shown that, like synovial pDCs, CD123+ DCs in
the T-cell area of human tonsil are also nuclear RelB- [23].
The data suggest either that activation of pDCs is not asso-
ciated with nuclear translocation and transcriptional activity
of RelB or that conditions in tonsil and synovium do not
induce sufficient RelB translocation for detection by immu-
nohistochemistry [26,57]. As preliminary studies in vitro
demonstrate induction of RelB in PB pDCs after stimula-
tion with lipopolysaccharide and CpG, and reduced pro-
duction of IFN-α by pDCs in RelB-deficient mice, it is likely
that RelB activation does accompany pDC activation. How-
ever, RelB translocation might be quantitatively reduced or
RelB might be more rapidly degraded in the nucleus of
pDCs than of myeloid DCs in inflamed tissues [58].
Of relevance to the RA inflammatory lesion, stimulation of
blood pDC precursors with signals including CD154, influ-
enza virus, or CpG oligonucleotides induces production of
large amounts of cytokines, including IFN-α, IFN-β, and
TNF-α; induction of DC differentiation; and stimulation of
APC function [3,39,44,59]. Although inhibitory effects of
SF on DC function, and thus on T-cell proliferation and
cytokine production, are confirmed here [21,39,60], fac-
tors in the RA SF environment, such as IL-3 and CD154,
Figure 5
CD123+ and CD11c+ synovial fluid (SF) dendritic cells (DCs) are efficient antigen-presenting cells (APCs) and induce secretion of tumor necrosis  factor α CD123+ and CD11c+ synovial fluid (SF) dendritic cells (DCs) are efficient antigen-presenting cells (APCs) and induce secretion of tumor necrosis 
factor α. Freshly sorted CD123+CD11c- or CD11c+CD123- DCs from either normal peripheral blood (PB) (a–d) or rheumatoid arthritis (RA) SF (e–
h) were incubated with 105 purified normal allogeneic T cells. T-cell proliferation was measured by [3H]thymidine incorporation of triplicate wells 
after 60 hours (a, e). Unstimulated T-cell proliferation was routinely <500 cpm. Data represent means ± standard error of the mean of triplicate wells 
and are from three individual PB and SF donors. The concentrations of IFNγ, IL-10, and tumor necrosis factor (TNF)-α were measured in superna-
tants of allogeneic mixed lymphocyte reactions stimulated by sorted PB (b–d) or SF DCs (f–h). Data are means of duplicate samples and are from 
two separate SF donors.Available online http://arthritis-research.com/content/7/2/R230
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may be sufficient to precondition the SF pDCs for efficient
APC function ex vivo [36,44]. IFN-γ, IL-10, and TNF-α were
produced in mixed lymphocyte reactions stimulated by
myeloid or pDCs derived from SF but not PB, potentially by
DCs or by T cells or both. In the tissue, as a result of antigen
presentation by myeloid DCs or pDCs, key effector
cytokines may be produced in perivascular areas in RA,
located strategically close to endothelial cells, as well as
incoming leukocytes. It is not known whether pDCs are
capable, like myeloid DCs, of migration from synovial tissue
to draining lymph nodes. However, it seems probable that
pDCs conditioned by local IL-3 and CD154, or even viral or
bacterial products transported to the synovium, predomi-
nantly play local proinflammatory and antigen-presenting
roles, through secretion of cytokines such as IFN-α and
possibly TNF-α [61,62].
Conclusion
pDCs are recruited to RA synovial tissue and comprise an
APC population distinct from the previously described
nuclear RelB+ synovial DCs. The APC function of pDCs is
greater in SF than in PB. Activated pDCs and interacting T
cells may contribute significantly to the inflammatory envi-
ronment in RA.
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